Head of Translational Sciences, Drug Design, Cambridge, MA

Isomorphic Labs is applying frontier AI to help unlock deeper scientific insights, faster breakthroughs, and life-changing medicines with an ambition to solve all disease. The future is coming. A future enabled and enriched by the incredible power of machine learning. A future in which diseases are curtailed or cured starting with better and faster drug discovery.  Come and be part of an interdisciplinary team driving groundbreaking innovation and play a meaningful role in contributing towards us achieving our ambitious goals, while being a part of an inspiring and collaborative culture. The world we want tomorrow is the one we’re building today. It starts with the culture at this company. It starts with you.  About Iso Isomorphic Labs (IsoLabs) was launched in 2021 to advance human health by building on and beyond the Nobel-winning AlphaFold system. Since then, our interdisciplinary team of drug discovery experts and machine learning specialists has built powerful new predictive and generative AI models that accelerate scientific discovery at digital speed. Our name comes from the belief that there is an underlying symmetry between biology and information science. By harnessing AI’s powerful capabilities, we can use it to model complex biological phenomena to help design novel molecules, anticipate how drugs will perform and develop innovative medicines to treat and cure some of the world’s most devastating diseases. We have built a world-leading drug design engine comprising AI models that are capable of working across multiple therapeutic areas and drug modalities. We are continually innovating on model architecture and developing cutting-edge capabilities to advance rational drug design. Every day, and with each new breakthrough, we’re getting closer to the promise of digital biology, and achieving our ambitious mission to one day solve all disease with the help of AI.   About the Translational Sciences Team We are building a dynamic drug discovery team in Boston, as part of Isomorphic Labs’ approach to transform how drugs are designed. Translational Sciences is an essential component of this effort, establishing and evolving our biological understanding of how to correct dysregulated systems in disease. This team will have impact across the full breadth of our portfolio, from critical input on target selection to essential partnership on biomarker development, to enable pharmacodynamic modulation and target engagement in the clinic.  Domain expertise will be critical to design translational strategies for programs, evolving our understanding of mechanisms and modes of action as programs progress.  This team will be highly collaborative and need to establish strong scientific relationships with multiple groups in the company, from Medicinal Chemists to Applied Machine Learning Scientists, creating a powerful symbiotic relationship that drives our internal and collaborative portfolios.   What you will do  Lead the preclinical Translational Science strategy in close collaboration with the Computational Biology, Preclinical Development and Translational Medicine teams, ensuring lifecycle-spanning screening cascades and biomarker assays are in place to guide programs toward clinical success. Ensure scientific rigor and "decision-quality" data across all local programs. Partner with the VP, Head of Drug Discovery, Cambridge, MA to recruit and retain a world-class team of scientists. Maintain a seamless collaborative loop with the Head of Translational Sciences, London to ensure resource sharing, protocol alignment, and unified scientific standards. Direct all in vitro and in vivo biology operations in Cambridge, MA through a network of CROs to generate, ingest and interpret high quality experimental data efficiently to support all aspects of our drug design programs from HitID through to IND. Foster a site culture of high accountability, rapid iteration, and scientific curiosity. Serve as a key internal consultant and advisor for global target discovery, providing critical technical assessment, feasibility analysis, and translational "stress testing" for new targets under consideration. Collaboratively execute program progression and determine resource allocation. Facilitate the transfer best practices and know-how between the UK and US sites to maximize R&D efficiency. Manage relationships with CROs and academic collaborators to extend the site’s internal capabilities.   Skills and qualifications  Essential: PhD in relevant Biological Sciences. Solid foundation in Translational Sciences with a minimum of 10+ years previous industrial experience within a pharma/biotech/CRO setting, with a clear trajectory of increasing responsibility.  Proven track record of successfully navigating the discovery to IND transition, demonstrating mastery of molecular mechanisms. Track record of delivering multiple programs by formulating and implementing fit for pu